quiescin Q6 Inhibitors
Quiescin Q6 inhibitors belong to a specific class of chemical compounds that have attracted attention in the field of enzymology and redox biochemistry. Quiescin Q6, also known as QSOX1 (Quiescin Sulfhydryl Oxidase 1), is an enzyme involved in facilitating disulfide bond formation in proteins. Disulfide bonds are crucial for stabilizing the three-dimensional structure of proteins and are essential for their proper folding and function. Quiescin Q6 plays a pivotal role in this process by catalyzing the oxidation of free thiols in proteins, thereby promoting the formation of disulfide bonds. Quiescin Q6 inhibitors are chemical compounds designed to interact with Quiescin Q6 and modulate its enzymatic activity, potentially influencing the redox state of proteins and their structural stability.
The mechanism of action of Quiescin Q6 inhibitors typically involves their binding to the active site or specific regions of the Quiescin Q6 enzyme. This interaction can lead to alterations in the enzyme's activity, potentially inhibiting its ability to catalyze the oxidation of protein thiols and the formation of disulfide bonds. As a result, Quiescin Q6 inhibitors may have implications for protein folding, stability, and function, affecting various cellular processes that rely on properly folded proteins. The study of Quiescin Q6 inhibitors is significant in advancing our understanding of protein biochemistry, redox regulation, and the intricate mechanisms governing protein folding and maturation. Furthermore, it contributes to the broader field of enzymology, shedding light on the molecular processes that underlie the formation of disulfide bonds in proteins and their impact on cellular physiology.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $176.00 $426.00 | 43 | |
Doxorubicin intercalates DNA and inhibits topoisomerase II, potentially leading to reduced transcription and subsequent decreased expression of various genes, possibly including QSOX1. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
Mithramycin A binds to GC-rich DNA sequences, inhibiting transcription factors from binding to promoters, which might reduce QSOX1 expression. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
Camptothecin inhibits topoisomerase I, which could result in DNA damage and potentially downregulate gene expression, including QSOX1. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is an inhibitor of histone deacetylases (HDACs), which can alter chromatin structure and affect gene expression, potentially decreasing QSOX1 expression. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine incorporates into RNA and DNA and can inhibit DNA methyltransferase, potentially leading to the reactivation of silenced genes or the silencing of active genes like QSOX1. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $138.00 $380.00 | 101 | |
Cisplatin forms DNA adducts, which may interfere with transcription and could nonspecifically inhibit the expression of some genes, including QSOX1. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine can inhibit DNA and RNA synthesis and likely has a global effect on gene expression, which could include the downregulation of genes such as QSOX1. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG132 inhibits proteasomes, which could lead to altered regulation of transcription factors and indirectly affect gene expression, potentially including QSOX1. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Bortezomib is a proteasome inhibitor that can affect the stability of proteins involved in cell cycle regulation and gene expression, which might affect QSOX1 levels. | ||||||
Rocaglamide | 84573-16-0 | sc-203241 sc-203241A sc-203241B sc-203241C sc-203241D | 100 µg 1 mg 5 mg 10 mg 25 mg | $275.00 $474.00 $1639.00 $2497.00 $5344.00 | 4 | |
Rocaglamide has been shown to inhibit protein synthesis translationally, which could lead to a reduction in the levels of proteins such as QSOX1. | ||||||